Skip to main content
. 2014 Sep 2;13:345. doi: 10.1186/1475-2875-13-345

Table 4.

Factors that facilitated the uptake of evidence as reported by respondents

Donors MoH NMS NDA Service providers CSO Pharmaceutical company Media Researchers Total
Characteristics of available evidence 10 20 2 14 4 4 3 57
MoH institutional capacity to lead the KT process 1 8 2 2 3 4 20
Partnerships for KT 3 7 1 3 2 1 1 18
Availability of tools and inputs to implement evidence 2 5 9 1 17
WHO intervention 3 4 1 1 9